I think markets don't properly value the R&D value and value of partnerships and expertise and feedback gained through prototyping. Having said that, I think we are quite likely to go to below 10 cents. It would be good to see the technical milestones coupled with a few more business milestones.
- Forums
- ASX - By Stock
- SAS
- Ann: Quarterly Activities and Cashflow Report
Ann: Quarterly Activities and Cashflow Report, page-4
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SAS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online